391 related articles for article (PubMed ID: 32603690)
1. Regulation of inflammation in diabetes: From genetics to epigenomics evidence.
Diedisheim M; Carcarino E; Vandiedonck C; Roussel R; Gautier JF; Venteclef N
Mol Metab; 2020 Nov; 41():101041. PubMed ID: 32603690
[TBL] [Abstract][Full Text] [Related]
2. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis.
Sawalha AH; Dozmorov MG
J Autoimmun; 2016 Feb; 67():76-81. PubMed ID: 26492816
[TBL] [Abstract][Full Text] [Related]
5. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic model of cardiac enhancers with application to genome wide association studies.
Sahu AD; Aniba R; Chang YP; Hannenhalli S
Pac Symp Biocomput; 2013; ():92-102. PubMed ID: 23424115
[TBL] [Abstract][Full Text] [Related]
7. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
[TBL] [Abstract][Full Text] [Related]
8. Risk variants disrupting enhancers of T
Gao P; Uzun Y; He B; Salamati SE; Coffey JKM; Tsalikian E; Tan K
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7581-7590. PubMed ID: 30910956
[TBL] [Abstract][Full Text] [Related]
9. The complexity of epigenetic diseases.
Brazel AJ; Vernimmen D
J Pathol; 2016 Jan; 238(2):333-44. PubMed ID: 26419725
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional enhancers: from prediction to functional assessment on a genome-wide scale.
Tobias IC; Abatti LE; Moorthy SD; Mullany S; Taylor T; Khader N; Filice MA; Mitchell JA
Genome; 2021 Apr; 64(4):426-448. PubMed ID: 32961076
[TBL] [Abstract][Full Text] [Related]
11. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
[TBL] [Abstract][Full Text] [Related]
12. Identification of atrial fibrillation associated genes and functional non-coding variants.
van Ouwerkerk AF; Bosada FM; van Duijvenboden K; Hill MC; Montefiori LE; Scholman KT; Liu J; de Vries AAF; Boukens BJ; Ellinor PT; Goumans MJTH; Efimov IR; Nobrega MA; Barnett P; Martin JF; Christoffels VM
Nat Commun; 2019 Oct; 10(1):4755. PubMed ID: 31628324
[TBL] [Abstract][Full Text] [Related]
13. Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk.
Novikova G; Andrews SJ; Renton AE; Marcora E
Mol Neurodegener; 2021 Apr; 16(1):27. PubMed ID: 33882988
[TBL] [Abstract][Full Text] [Related]
14. Enhancer target prediction: state-of-the-art approaches and future prospects.
Umarov R; Hon CC
Biochem Soc Trans; 2023 Oct; 51(5):1975-1988. PubMed ID: 37830459
[TBL] [Abstract][Full Text] [Related]
15. Genetic effects of sequence-conserved enhancer-like elements on human complex traits.
Zhu X; Ma S; Wong WH
Genome Biol; 2024 Jan; 25(1):1. PubMed ID: 38167462
[TBL] [Abstract][Full Text] [Related]
16. Osteoarthritis year in review 2019: genetics, genomics and epigenetics.
Reynard LN; Barter MJ
Osteoarthritis Cartilage; 2020 Mar; 28(3):275-284. PubMed ID: 31874234
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional enhancers: from properties to genome-wide predictions.
Shlyueva D; Stampfel G; Stark A
Nat Rev Genet; 2014 Apr; 15(4):272-86. PubMed ID: 24614317
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance.
Zhang P; Amarasinghe HE; Whalley JP; Tay C; Fang H; Migliorini G; Brown AC; Allcock A; Scozzafava G; Rath P; Davies B; Knight JC
Genome Biol; 2022 Jun; 23(1):136. PubMed ID: 35751107
[TBL] [Abstract][Full Text] [Related]
19. Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention.
Tough DF; Prinjha RK
Epigenomics; 2017 Apr; 9(4):573-584. PubMed ID: 27925476
[TBL] [Abstract][Full Text] [Related]
20. cepip: context-dependent epigenomic weighting for prioritization of regulatory variants and disease-associated genes.
Li MJ; Li M; Liu Z; Yan B; Pan Z; Huang D; Liang Q; Ying D; Xu F; Yao H; Wang P; Kocher JA; Xia Z; Sham PC; Liu JS; Wang J
Genome Biol; 2017 Mar; 18(1):52. PubMed ID: 28302177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
